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A B S T R A C T
Underage patients with Borderline Personality Pathology (BPP) are in need of specialised psychotherapeutic
treatment. A handful of these treatments, including Adolescent Identity Treatment (AIT) and Dialectical
Behavior Therapy for Adolescents (DBT-A), have been adapted for adolescent patients. Psychotherapy research
has shown that the outcome of different psychotherapeutic approaches can be very similar despite conceptual
and practical differences between the theoretical models. Therefore, to understand what really works in psy-
chotherapy, it is necessary to investigate the psychotherapeutic process and its effects on the patient.
This paper presents a study design for process-outcome research, integrating (1) a classical outcome design,
comparing AIT and DBT-A in a non-inferiority trial assessing changes in psychosocial functioning at 12 months
after baseline as primary outcome; and (2) a process research design, addressing multiple BPP and psy-
chotherapy relevant factors. These factors include well-studied generic variables such as the psychotherapeutic
alliance, more recent approaches such as video-based identification of significant therapeutic events, as well as
more experimental approaches such as psychophysiological markers measured during the therapeutic sessions.
The use of repeated measures and the methodological pluralism which includes event and micro-process
analyses has been recommended for psychotherapy research aiming at a better understanding of the interplay of
factors at work to narrow the gap between research and practice in this field.
1. Introduction
It is important to diagnose personality disorders (PD) already in
adolescence [1–3]. Tackett et al. [4] have outlined the usefulness of a
life span perspective on personality pathology from early childhood to
later life. Reliability, validity, temporal stability and prevalence of the
borderline personality disorder (BPD) diagnoses in adolescents are si-
milar to those in adulthood [5–7]. The prevalence of BPD in adolescents
is estimated between 1 and 5% [2]. BPD is associated with clinically
significant impairments in social, occupational, and other areas of
functioning [5,7,8]. Experts broadly agree on the necessity of specia-
lised interventions and the importance of early treatment to limit def-
icits in psychosocial functioning [5,9–11]. Various treatment programs
for BPD have been developed in the last decades [12–14]. Most of them
have been adapted for adolescents. Alongside patients with full syn-
drome BPD the current study also allows for inclusion of patients who
only fulfil a subset of the required criteria to target young patients who
present with (yet) milder (sub-threshold) forms. To designate this po-
pulation the term Borderline Personality Pathology (BPP) is used in the
following. At least four manualized therapeutic approaches for
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adolescents with BPP are available: Dialectical Behavior Therapy for
Adolescents (DBT-A), Mentalization Based Treatment for Adolescents
(MBT-A), Adolescent Identity Treatment (AIT) and Schema-focused
Psychotherapy for Adolescents (SFT-A) [15–18].
The effects of different psychotherapeutic approaches can be very
similar despite conceptual and practical differences between the models
(equivalence paradox or dodo bird verdict) [19]. This effect has been
observed in multiple meta-analyses and has led to a paradigmatic shift
in psychotherapy research from outcome to process research [20–22].
Pure outcome designs focus on post therapeutic change compared to
baseline. Therefore, the actual psychotherapeutic processes remain in a
“blackbox”. Change process research is needed alongside randomised
controlled trials [23] to understand common and specific factors at
work in different types of psychotherapy [20,24]. A better under-
standing of these factors might help improving therapeutic interven-
tions, designing optimal treatments for specific patient populations and
improving the translation of psychotherapeutic models into clinical
practice [25,25].
Here, we present the design of a process-outcome study in-
vestigating the psychotherapeutic treatment of adolescents with BPP
using two specialised approaches: AIT and DBT-A. These approaches
differ in their concepts and goals. Psychosocial functioning, that has
been shown to be highly impaired in adolescent patients with BPD [26]
and presents an important target for health care interventions, has been
selected as main outcome variable for the outcome comparison. In ac-
cordance with the dodo bird verdict [19], relative equivalence in the
improvement of psychosocial functioning due to both DBT-A and AIT is
expected.
Beyond this outcome comparison, the psychotherapeutic process is
investigated to reach a better understanding of the change mechanisms
of AIT and DBT-A. The relative difference of both models regarding
their theoretical foundation, bears promise to identify and uncover
shared and specific factors. Well investigated generic measures of the
psychotherapeutic process as well as more experimental assessments
were included in the study design, to cover a broad range of potential
variables of interest.
2. Methods
The study is registered at clinicaltrials.gov (NCT02518906) [27].
Ethical approval for this study was obtained from the local ethics
committees. All adolescents and their therapists provide their written
informed consent prior to participation in the trial. Post-trial care is
ensured by the local clinical teams.
The methods section first describes the targeted population, the
interventions and the setting. The outcome and process questions and
methods are outlined in separate sections.
2.1. Population
The targeted patients are adolescents with Borderline Personality
Pathology (BPP) and identity diffusion, a core symptom of different
types of PD [28]. The following inclusion criteria are applied: age
13–19 years; ≥ 3 BPD criteria present (assessed with the Structured
Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II)
[29]); identity diffusion (Assessment of Identity Development in Ado-
lescence (AIDA) Total T-score > 60) [30]. Exclusion criteria are: an
intelligence quotient< 80; psychotic disorders; pervasive develop-
mental disorders; severe somatic or neurological disorders; severe and
persistent substance addiction; antisocial PD (omitting the age criteria);
and necessity of inpatient treatment. The instruments used for de-
termining the inclusion/exclusion criteria are listed in Table 1 under
“screening”. Necessity for inpatient treatment was evaluated during
screening by a psychiatrist. Both male and female patients are enrolled.
Patients drop out of the study if they require prolonged inpatient
treatment (> 2 weeks) beyond short-term crisis intervention, if a
patient does not want to continue the treatment or does not comply to
the respective therapeutic framework. Dropouts will be asked to par-
ticipate in follow-up assessments. To improve participant retention,
patients receive a financial compensation. In Basel and Heidelberg
patients receive financial compensations after each scientific assess-
ment outside of routine clinical care. The amounts vary according to the
length of the respective assessment. In Basel patients receive a total of
(the equivalent to) $400; in Heidelberg $295. In Santiago the treatment
is offered free of charge for study participants. Differences between
centres are due to regional economic and health care system differ-
ences.
The required sample size for the outcome part was calculated for the
primary endpoint at 12 months after baseline using the Clinical Global
Assessment Scale (CGAS) [31] (psychosocial functioning) as measure of
primary outcome. The sample size calculation assumes a mean CGAS
score of 50 points (SD=7.5) at baseline and 62 points at the primary
endpoint. As previously no psychotherapy studies on adolescent BPP
patients used psychosocial functioning as primary outcome, these as-
sumptions are based on a landmark study on adolescents with another
severe mental disorder (major depressive disorder) by Vitiello et al.
[32] which employed the CGAS as primary outcome. Furthermore, it
has been assumed that the CGAS scores are multivariate normally dis-
tributed (covariance: 0.7). The sample size was calculated based on
data simulation. For every sample size ni= 1,...,26=10, ..., 60, arti-
ficial patient data were generated R=500 times. To test how the un-
known treatment difference between AIT and DBT-A affects the re-
quired sample size, the treatment effect of AIT has been variated from
9.3 to 21.3 points. For each simulation, the difference of the treatment
success has been estimated together with the 95% confidence interval
using a linear model to check whether the confidence interval de-
scribing the difference of the two study arms was completely above the
predefined margin of −7.5. Assuming that AIT and DBT-A perform
equally well, a sample size of n=23 patients would be sufficient to
have the confidence interval of their difference above the margin of
−7.5 in 80% of the cases (power of 0.8). Additionally, expecting a
dropout rate of 20%, a sample size of 29 patients per study arm is
needed.
2.2. Psychotherapeutic interventions and setting
Psychotherapists are psychologists or physicians who underwent or
are currently undergoing psychotherapy training to obtain the specialist
degree. Additionally, all psychotherapists received specific training for
AIT or DBT-A. Regular supervisions of the psychotherapeutic work are
taking place at each centre to ensure the psychotherapists’ adherence
and competence.
2.2.1. Adolescent Identity Treatment (AIT)
AIT [17] is a psychodynamic approach for the treatment of PD in
adolescents that integrates modified elements of Transference-Focused
Psychotherapy (TFP) [33] with psychoeducation, behaviour-oriented
home plans, and work with parents. Like in TFP, the main techniques
are clarification, confrontation and interpretation, with an emphasis on
the affects in the here and now, as well as the dominant object re-
lationship dyads. During the psychoeducation part of the treatment,
both patients and parents are informed about the etiology and course of
PD symptoms in adolescents, as well as the specificities of relationship
building and maintaining, autonomy, limit setting, and affect regula-
tion in adolescent BPD patients. A written homeplan organizes the overt
behavioural interactions between the adolescent and his/her family,
provides rewards and consequences for behaviour and clarifies dis-
crepancies of perception between the adolescents and their family.
Parents are intensively included in the therapeutic process.
AIT is a manualized outpatient approach. In this study, it contains
25 weekly face-to-face sessions with the adolescents, and 5–8 sessions
with their parents. Time points of these parent sessions are planned
R. Zimmermann et al. Contemporary Clinical Trials Communications 12 (2018) 182–191
183
Ta
bl
e1
Ou
tco
me
ins
tru
me
nt
s.
Ty
pe
Ins
tru
me
nt
Pr
eA
sse
ssm
en
t
Th
era
pe
ut
ic
Pr
oc
ess
Fo
llo
w-
up
Sc
ree
nin
g
Ba
sel
ine
3r
dS
ess
ion
Be
for
ee
ac
h
Se
ssi
on
Du
rin
ge
ac
h
Se
ssi
on
Af
ter
ea
ch
Se
ssi
on
Tu
rn
of
ea
ch
Mo
nt
h
13
th
Se
ssi
on
Po
st
Th
era
py
12
Mo
nt
hs
aft
er
Ba
sel
ine
24
Mo
nt
hs
aft
er
Ba
sel
ine
Pr
e-
an
dP
os
tT
he
rap
y
As
ses
sm
en
ts
As
ses
sm
en
to
fI
de
nt
ity
De
ve
lop
me
nt
in
Ad
ole
sce
nc
e(
AI
DA
)
x
x
x
x
Str
uc
tu
red
Cl
ini
ca
lIn
ter
vie
w
for
DS
M-
IV
Ax
is
II
Pe
rso
na
lit
yD
iso
rd
ers
(SK
ID
-II
)
x
x
x
x
W
ec
hs
ler
Int
ell
ige
nc
eS
ca
le
for
Ch
ild
ren
(H
AW
IK
)O
R
Re
yn
old
sI
nt
ell
ec
tu
al
Sc
ree
nin
g
Te
st
(R
IST
)a
x
Mi
ni
Int
ern
ati
on
al
Ne
ur
op
sy
ch
iat
ric
Int
erv
iew
for
Ch
ild
ren
an
dA
do
les
ce
nt
s
(M
IN
I-K
ID
)
x
x
x
Ch
ild
ren
Gl
ob
al
As
ses
sm
en
tS
ca
le
(C
GA
S)b
x
x
x
x
Co
lum
bia
Im
pa
irm
en
tS
ca
le
-P
are
nt
Ve
rsi
on
(C
IS-
P)
x
x
x
x
Co
lum
bia
Im
pa
irm
en
tS
ca
le
-Y
ou
th
Ve
rsi
on
(C
IS-
Y)
x
x
x
x
Cl
ini
ca
lG
lob
al
Im
pr
ess
ion
sS
ca
le
(C
GI
)
x
x
x
x
Sc
ho
ol
Fu
nc
tio
nin
gR
ati
ng
(SF
R)
x
x
x
x
Be
ck
De
pr
ess
ion
Inv
en
tor
yI
I(
BD
I-I
I)
x
x
x
Ch
ild
ho
od
Tr
au
ma
Qu
est
ion
na
ire
(C
TQ
)
x
Mo
vie
for
th
eA
sse
ssm
en
to
fS
oc
ial
Co
gn
iti
on
(M
AS
C)
x
x
x
KI
DS
CR
EE
N
x
x
x
Le
ve
ls
of
Pe
rso
na
lit
yF
un
cti
on
ing
Qu
est
ion
na
ire
(L
oP
F-Q
12
–1
8)
x
x
x
Str
en
gth
sa
nd
Di
ffi
cu
lti
es
Qu
est
ion
na
ire
(SD
Q)
x
x
x
Pa
ren
tin
gS
tre
ss
Ind
ex
(P
SI)
x
x
x
Bo
rd
erl
ine
Sy
mp
tom
Lis
t(
BS
L-2
3)
x
x
x
Se
lf-
Inj
ur
iou
sT
ho
ug
ht
sa
nd
Be
ha
vio
rs
Int
erv
iew
(SI
TB
I)
x
x
x
x
Za
na
rin
iR
ati
ng
Sc
ale
for
Bo
rd
erl
ine
Pe
rso
na
lit
yD
iso
rd
er
(Z
AN
-B
PD
)
x
x
x
x
Pr
oc
ess
Re
sea
rch
Qu
est
ion
na
ire
sc
Se
ssi
on
Ev
alu
ati
on
Qu
est
ion
na
ire
for
th
e
Pa
tie
nt
(SE
Q)
x
Se
ssi
on
Ev
alu
ati
on
Qu
est
ion
na
ire
for
th
e
Th
era
pis
t(
SE
Q)
x
Yo
ut
h
Ou
tco
me
Qu
est
ion
na
ire
Se
lf-
Re
po
rt
(Y
OQ
-SR
)
x
x
x
x
x
W
or
kin
gA
llia
nc
eI
nv
en
tor
yf
or
Pa
tie
nt
s
(W
AI
)
x
x
x
W
or
kin
gA
llia
nc
eI
nv
en
tor
yf
or
Th
era
pis
ts
(W
AI
)
x
x
x
Cr
ed
ibi
lit
y/
Ex
pe
cta
nc
yQ
ue
sti
on
na
ire
Pa
ren
ts
(C
EQ
)
x
Cr
ed
ibi
lit
y/
Ex
pe
cta
nc
yQ
ue
sti
on
na
ire
Pa
tie
nt
s(
CE
Q)
x
x
Pr
oc
ess
Re
sea
rch
Vi
de
o
Ob
ser
ve
rR
ati
ng
s
Ge
ne
ric
Ch
an
ge
Ind
ica
tor
s(
GC
I)
x
Ru
ptu
res
&
Re
so
lut
ion
s(
R&
R)
x
Th
era
pis
tI
nt
erv
en
tio
ns
x
(co
nti
nu
ed
on
ne
xt
pa
ge)
R. Zimmermann et al. Contemporary Clinical Trials Communications 12 (2018) 182–191
184
according to the needs of the individual patients in accordance with the
therapeutic process. Duration of an AIT therapy is 6–8 months ap-
proximately, with times of holidays or missed appointments considered.
2.2.2. Dialectical behavior treatment for adolescents (DBT-A)
DBT-A [15] is an adaptation of the manualized treatment program
DBT that has originally been developed for adults with BPD. While DBT
is based on the therapeutic principles of Cognitive Behaviour Therapy,
the major modification lies in the integration of Zen Buddhist oriented
ideas to accept the specific vulnerabilities of BPD patients as being
resistant to change. Thus, the dialectical approach alters between the
focus on change of behaviours and attitudes on the one hand, and the
focus on accepting the vulnerabilities on the other hand.
In line with the adult version, DBT-A comprises a combination of an
outpatient individual therapy and a skills training in groups. For DBT-A,
skills taught were modified, with some skills removed and a new
module called “Walking the Middle Path” was added to help achieve a
balance between validation and change in family environments.
Overall, DBT-A includes simplified materials and has a stronger focus
on working with caregivers and other systems involved. In this study,
DBT-A contains 25 individual sessions as well as 20 sessions of skills
training. These sessions are also carried out within 6–8 months.
2.2.3. Setting
Recruitment takes place at three centres, each carries out one of the
investigated treatment approaches:
• AIT centre 1: Child and Adolescent Psychiatric Hospital of the
Psychiatric University Hospitals Basel, Switzerland.• AIT centre 2: Schilkrut Medical Institute (A. Borzutzky, P. Foelsch)
jointly with the Millennium Institute for Research in Depression and
Personality, Santiago, Chile.• DBT-A centre: Clinic of Child and Adolescent Psychiatry, Centre for
Psychosocial Medicine, University of Heidelberg, Germany.
2.3. Outcome research
Interplay of outcome and process research is illustrated in Fig. 1.
The outcome part of the study addresses the following questions: In
adolescents suffering from BPP, does an intensive outpatient treatment
with the new approach AIT lead to an outcome that is comparable (non-
inferior) to an intensive treatment with DBT-A? The non-inferiority
design was chosen since DBT-A already has been established as an ef-
fective treatment [15,34,35].
Outcome parameters are collected at 4 visits: Baseline (before
therapy), Post treatment (immediately after the end of therapy, time
from baseline can vary according to therapy length), a First Follow-up (1
year after Baseline, 1yFU) and a Second Follow-up (2 years after
Baseline, 2yFU). 1yFU is defined as primary end-point. Post Treatment
and 2yFU are used to illustrate symptom course and stability of im-
provement over time.
2.3.1. Outcome parameters
The main outcome criterion is psychosocial functioning, assessed
with the CGAS [31]. This scale has a range of 1–100 points, with a
score< 10 signifying that the patient needs constant supervision. while
a score of> 80 describes a good or even very good level of functioning.
For a holistic assessment, secondary outcome parameters represent the
domains general psychopathology, personality functioning, borderline
specific symptoms, patient's quality of life and stress of the parents. An
overview of all outcome parameters is given in the upper part of
Table 1.
Hypothesis A. AIT is not inferior to DBT-A in terms of improvement in
psychosocial functioning.Ta
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2.4. Process research
The aim of psychotherapy process research is to answer the question
“How does psychotherapy work?” [36]. In general, answering this
question requires identifying and understanding mechanisms of patient
change i.e. how they are brought about by what happens during psy-
chotherapeutic treatment. Before mechanisms can be established it is
important to explore the parameters at work. These parameters are not
static but considered to vary over time and are, therefore, captured with
repeated measures.
Process-outcome research correlates so called mediator variables
with outcome. This outcome can consist of “classical” pre-post-outcome
parameters such as those described in the previous section. However, to
reduce the distance between mediators and outcome and to observe
more direct dependencies it is useful to repeatedly evaluate outcome
(patient change) throughout the psychotherapeutic process.
2.4.1. Outcome and patient change within the psychotherapeutic process
2.4.1.1. Intermediate outcome. Intermediate outcome, defined as the
patient's change observed over several sessions of a treatment [37], is
monitored with the Youth Outcome Questionnaire Self Rating [38,39]
(Y-OQ-SR) on a monthly basis. The questionnaire is constructed to be
sensitive to change over short periods of time. It consists of a total
distress score and six subscales: interpersonal distress, somatic
complaints, interpersonal relations, social problems, behavioural
dysfunction and critical items (e.g. hallucinations or suicidal ideas).
The Y-OQ-SR is also applied at baseline, post treatment and follow-ups,
thus assuring continuity of assessment over the total period of
investigation.
Hypothesis B1.1. Improvement in intermediate outcome is positively
correlated to the (pre-post) overall outcome level.
Hypothesis B1.2. Symptoms measured on the intermediate outcome
level decrease throughout psychotherapy.
We are, furthermore, interested in the individual courses of change
and how they affect overall psychotherapeutic outcome. In which phase
of the therapy do changes occur? Are these changes stable over time or
can there be temporary setbacks? A major question of practical re-
levance is whether early symptom changes predict overall outcome.
2.4.1.2. Patient change in process: the Generic Change Indicators
model. Significant event approaches are considered to be among the
promising research strategies to advance the field of psychotherapy
process research [19,23]. Change Moments (CM) are significant
therapeutic events measured by the Generic Change Indicators model
(GCI, [40]). They represent key moments of psychotherapeutic
treatment. According to this model, “generic psychotherapeutic
change is related to client's transformations on their subjective
perspective regarding themselves, their problems and symptoms, and
their relationship with the environment in which they occur” [41]. The
term “generic” refers to the idea that these change indicators are not
limited to certain psychotherapeutic models. Their genericity has been
empirically shown [42]. There are 19 sequentially ordered change
indicators, which are ordered to represent theoretically necessary steps
the patient should take to achieve psychotherapeutic change. The 19
indicators are grouped into the following three stages: 1) Initial
consolidation of the therapeutic relationship structure; 2) Increase in
permeability towards new understandings; and 3) Construction and
consolidation of a new understanding. The validity of this staging
model has been empirically confirmed [40]. The model allows
capturing changes which happen outside of the psychotherapy
sessions (called extra session CM) but which are addressed during
psychotherapy. CM are identified based on video analysis of all
psychotherapeutic sessions by independent trained observers. It is
important that non-verbal as well as verbal behaviour is taken into
account for valid rating. As shown previously [40] in other patient
Fig. 1. Combination of outcome- and process-research.
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samples CM are correlated to outcome.
Hypothesis B2.1. CM are positively correlated to intermediate and
overall outcome.
Hypothesis B2.2. Total number of CM is less strongly correlated to
outcome than a progression from lower level CM to higher level CM,
which represents the passing through (according to the model)
necessary steps of psychotherapeutic change.
2.4.2. Mediators of therapeutic change
2.4.2.1. Psychotherapeutic alliance. Psychotherapeutic alliance is
among the most studied common factors in psychotherapy and
robustly predicts psychotherapeutic outcome [43]. Patients with
personality disorders have difficulties to develop stable interpersonal
relationships, which also affects the psychotherapeutic alliance [44].
Therefore, psychotherapeutic alliance can be hypothesised to be a
central mediator variable of psychotherapeutic outcome in these
patients.
The Working Alliance Inventory (WAI; [45]) conceptualises alliance
in terms of agreement on goals, task and bond. It is filled out before the
3rd, 12th and final sessions by both, patients and therapists.
Hypothesis B3.1. Working alliance is positively correlated to
intermediate outcome.
Hypothesis B3.2. Working alliance is positively correlated to
improvement in overall outcome.
2.4.2.2. Ruptures and resolutions (R&R). To come to a deeper
understanding of therapeutic alliance, the R&R model is applied. The
R&R model conceptualises alliance as a dynamic phenomenon [46] and
is based on video ratings of psychotherapeutic sessions. Ruptures are
deteriorations in the quality of the therapeutic relationship. They
represent inevitable interpersonal events [47,48]. Ruptures are
conceptualised to put into effect dysfunctional interpersonal patterns
and, therefore, are a window to work on these patterns [48]. Ruptures
are organised into two classes: withdrawal and confrontation. In
withdrawal ruptures, the patient disengages from the therapeutic
process and/or the therapist (e.g. falling silent). In confrontational
ruptures, the patient directly expresses anger or dissatisfaction towards
the therapist or the treatment. In the model, the therapist can react to
rupture episodes using resolution strategies. In the present study, R&R
episodes will be rated by trained observers according to the “Rupture
Resolution Rating System (3RS): Manual” based on video recordings of
the psychotherapeutic sessions [49]. According to the R&R model, it is
possible that ruptures and their resolutions promote occurrence of
change. Based on the results of [50] who also investigated R&R in
young patients with BPD, we hypothesise that:
Hypothesis B4.1. The occurrence of alliance ruptures follows an
inverted u-shaped trajectory across treatment time. This pattern
indicates intensive and frequent alliance ruptures during the middle
phase of the treatment.
Hypothesis B4.2. Intensive and frequent early ruptures are negatively
correlated to overall outcome.
Finally, sequence analyses of R&R and CM are of special interest
[23,51] to understand the effect of R&R in the occurrence of psy-
chotherapeutic change.
2.4.2.3. Treatment expectancy. Treatment expectancy plays a key role
in the process and outcome of psychotherapy [22,52,53]. Empirical
support for its importance also comes from placebo research. The
placebo effect is regarded as a well-founded psychobiological
phenomenon in which improvement in symptoms is explained by the
meaning and expectancy a patient attributes to the treatment [54–57].
BPD is difficult to treat and patients often have an ambiguous
relationship with the health care system based on multiple negative
experiences in former psychotherapies. Treatment expectancy might be
a crucial variable to address in the treatment of these patients. In the
present study, patients and parents are asked about their treatment
expectancy at the beginning and the 12th session (patients only) of
treatment. We apply the Credibility and Expectancy Questionnaire
(CEQ) (Devilly & Borkovec, 2000) which is a short self-report
questionnaire that consists of two factors, the cognitively based
credibility and the affectively based expectancy for treatment. The
credibility items ask how logical the offered therapy seems, how
successful patients think it will be, and how confident they are in
recommending it to others. The expectancy items ask how much
improvement they expect, how much they really feel it will help, and
how much improvement they really feel will occur.
Hypothesis B5.1. Higher treatment expectancy is correlated with
better overall outcome.
Hypothesis B5.2. Higher treatment expectancy is correlated with
better early working alliance (measured by WAI, as well as R&R).
2.4.2.4. Therapist interventions. From a clinical perspective, the
investigation of therapist interventions and the use of
psychotherapeutic techniques are of high relevance. However,
psychotherapy research has often failed to provide evidence for the
link between therapeutic model and outcome [19,58]. Based on this
experience, psychotherapy research moved away from investigating
broad comprehensive models, instead looking at what happens on a
restricted timescale aiming at constructing therapeutic models bottom
up. A further research problem is that psychotherapeutic interventions
do not work based on a dose to effect–response logic but rather seem to
depend on an adequate “responsiveness” [58], implying the therapist's
good timing, intuition, empathy as well as interactivity with the patient
[59]. It is of relevance to address the questions of therapist
interventions from a bottom up perspective in this sample as patients
with BPD are reckoned to be difficulty treated. The questions are “what
works in these patients and where are potential pitfalls?”.
Therapist interventions will be assessed from a generic, trans-
theoretical perspective, at the level of significant events (CM and R&R)
(i.e. speaking turns before, during and after these events). First, primary
therapist response modes (question, advisement, information, reflec-
tion, interpretation, and self-disclosure) will be evaluated. To measure
these techniques, we will use the ‘Techniques’ dimension of Therapeutic
Activity Coding System (TACS) [60]. Additionally, we will use the three
main ‘Communicative Intentions’ from the TACS (exploring, attuning
and resignifying) [61] jointly with the three main AIT techniques
(clarification, confrontation and interpretation) [17].
To address the problem of responsiveness, alliance will be in-
vestigated as a potential mediator of employed interventions [62].
Further mediators of the relation of significant events and interventions
will be the progression of the psychotherapeutic work in terms of time
(number of session) as well as attained level of the change indicators.
Hypothesis B6.1. Use of therapist interventions is mediated by
alliance.
Hypothesis B6.2. Use of therapist interventions is mediated by
progression of therapy (time in therapy).
Hypothesis B6.3. Use of therapist interventions is mediated by the
level of change CM.
2.5. Biological markers
In this study, electrocardiogram (ECG) and electrodermal activity
(EDA) are measured in patients and therapists in the psychotherapy
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sessions as well as during resting state. Saliva cortisol is measured in
patients and therapists before and after each therapy session, hair
cortisol in patients at pre- and post-assessment. The biological markers
are investigated for their potential to inform about relevant aspects of
the psychotherapeutic process as well as in correlation to patient
change.
During the psychotherapeutic sessions patients and therapists are
equipped with wearable ECG and EDA devices. Single lead surface ECG
with a fixed potential ground electrode was recorded from both patient
and therapist using Ag/AgCl electrodes (Kendall H135SG) with a
Shimmer ECG devices [63]. The first electrode was placed directly
under the centre of the right clavicula. The ground electrode was placed
3–5 cm below the first electrode. The second electrode was placed at
the same level as the ground electrode below the centre of the left
clavicula. This procedure was chosen so that patient and therapist were
able to attach the ECG device on their own and to avoid undressing of
the participants. The ECG signal was sampled at 1024 Hz. Electro-
dermal Activity was assessed using shimmer3 GSR + devices that
monitor activation of sweat glands via two reusable electrodes attached
to the index and middle finger of the non-dominant hand. In Heidel-
berg, ECG were recorded using an ekgMove 3 sensor (movisens GmbH,
Karlsruhe, Germany) attached to the participants chest at the base of
the sternum using a flexible belt with two integrated electrodes that
were watered before the recording. ECG signals were recorded at a
sampling rate of 1024Hz. The devices are synchronised to each other
and to the video signal. Saliva cortisol of both, patient and therapist, is
taken at the beginning and end of each session. Resting state measures
of all biological markers are taken at baseline, mid therapy and follow-
up visits (see Table 1).
2.5.1. Biological markers of outcome
A first question of interest is whether systematic changes of the
investigated biological markers can be observed over the psychother-
apeutic process and in the follow-up resting state visits compared to the
baseline assessments. While heart rate variability (HRV) is correlated
with borderline personality symptom severity in adolescents [64] its
change over the psychotherapeutic process has, furthermore, been
correlated to change in these symptoms [65]. This cardiac marker
might, therefore, be useful to track psychotherapeutic outcome in
adolescents with BPP. Similarly, the cortisol and electrodermal re-
sponses have been found to be altered in correlation to borderline
personality symptoms [66–69] and might change under psychother-
apeutic treatment.
Hypothesis C1.1. Increase in HRV over the course of the
psychotherapy is correlated to better overall outcome.
Hypothesis C1.2. Decrease of cortisol response over the course of the
psychotherapeutic treatment is correlated to better overall outcome.
2.5.2. Biological markers and significant therapeutic events
A second aim is to characterise these biological markers in corre-
lation to significant therapeutic events (CM and R&R). In analogy to the
Therapeutic Cycle Model [70,71], which states that psychotherapeutic
change is facilitated by appropriate cognitive and emotional circum-
stances, we hypothesise that patient's changes are facilitated under
certain physiological conditions, which can be characterised by the
proposed biomarkers.
Hypothesis C2.1. CM are more likely under certain conditions which
can be characterised by biological parameters.
Hypothesis C2.2. R&R are more likely under certain conditions which
can be characterised by biological parameters.
2.5.3. Interpersonal physiology
A further question of interest is interpersonal physiology [72]
during psychotherapy i.e. in this case the synchrony of patient and
therapist biosignals. It can be studied in a multitude of modalities (e.g.
psychophysiology, vocal frequency, motion energy analysis [73]) and
has been related to psychotherapeutic alliance [74]. For example,
concordance of EDA has been shown to be correlated to patient per-
ceived empathy of psychotherapists [75]. The phenomenon of inter-
personal physiology is an important upcoming topic in psychotherapy
research. It might be a basic mechanism of psychotherapy in which
patient and therapist have to create a shared psychotherapeutic space.
Hypothesis C3.1. Synchrony of biosignals is correlated to alliance.
Hypothesis C3.2. Synchrony of biosignals is correlated to overall
outcome.
3. Discussion
The presented design investigates the outcome and process of psy-
chotherapy in adolescents with BPP:
3.1. Outcome research
“Classical” outcome research with psychosocial functioning as pri-
mary end-point answers the question of the efficacy. The end-point has
been chosen as a fair comparator between the quite different psy-
chotherapeutic models and is arguably one of the most relevant and
generally valid treatment targets in this sample of adolescents.
In this outcome comparison, the allocation of the patients is not
randomised. Randomised controlled trials (RCT) have important ad-
vantages in reducing statistical biases [76]. There are, however, detri-
ments to RCTs: The efficacy-effectiveness gap [77,78] describes the
difference of performance under research (efficacy) and everyday
clinical practice (effectiveness) conditions [79]. This gap is important to
take into consideration. With the presented study design, we undertake
the evaluation of a clinical intervention in a specific set of patients
(adolescents with BPD) thus being obliged to use a multicentre design
to guarantee sufficient sample size, and the treatment approaches de-
scribed (AIT and DBT-A) are run in naturalistic settings, i.e. the in-
volved centres are specialized in the application of the respective in-
terventions. This gives our study, which also investigates the
therapeutic process, more ecological validity compared to a standard
RCT. In contrast, in order to implement a RCT, it would be necessary to
make both psychotherapeutic models available at all study centres.
However, psychotherapeutic formation is an expensive process and due
to the required investment psychotherapists tend to select the psy-
chotherapeutic formations based on personal attitudes and beliefs. A
possible solution could be the relocation of the psychotherapists.
However, this would multiply the costs of the clinical trial and, ad-
ditionally, the setting would be still artificial in contrast to the routinely
implemented psychotherapies. Consequently, we decided to let the in-
terventions be carried out in the respective specialised centres, thus
profiting from an “adversarial collaboration” [80] to implement a fair
and balanced study design. In this case, allocation to the study arms was
decided on by recruitment location. Despite the application of identical
inclusion criteria, the multicentre nature of the study might result in
differences between the three samples (e.g. severity of symptoms, ratio
of male to female patients, age) which might be related to study site
specifics. Statistical control for such effects is necessary. Additionally,
while the recruitment from specialised settings is necessary for the
feasibility of the study, it also might limit generalisation of the results to
other (less specialised) contexts.
3.2. Process research
The process part of the study aims at researching the question of
how therapy works. It relies on multiple approaches (i.e. measuring
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intermediate outcome, evaluating expectancy and alliance from the
patient and therapist points of view), identifying significant therapeutic
events (R&R and CM) as well as analysing micro process (therapist
interventions and psychophysiology).
This “systematic methodological pluralism” is intended and re-
commended for psychotherapy research [23,40]. Kazdin [25] points
out the importance of repeated application of instruments over the
psychotherapeutic process as a means of establishing mechanisms of
psychotherapeutic functioning in the sense that the mediator variables
should change before the outcome variable. The focus on clinical rea-
lities should help narrowing the evident gap between research and
practice in psychotherapy [19,81].
Hierarchical and latent variable modelling are options to address
the problem of multiple levels and timescales in the data set resulting
from this study design. It is our goal to not only observe inter-individual
differences, but also to consider intra-individual changes over time.
Thus, the time variable will be used as a quantitative variable in these
models to describe and understand the timely interdependence of the
observed process phenomena and their impact on the outcome vari-
ables. The sample size might in certain regards prove as one of the
major limitations of this study. Results will be partially explorative in
nature. However, this limitation should not prevent researchers from
addressing relevant questions. The field is relying on and developing a
number of data analytic instruments such as qualitative research [82],
case studies, time series and sequence analysis or methods derived from
dynamic systems theory [83].
An important aspect in studying the psychotherapeutic process is
considering external factors which can interact with the psychotherapy.
While external factors are considered in the present design by assessing
extra session change indicators, it is still possible that important ex-
ternal factors are missed.
The implementation of the psychotherapy research framework can
burden the patients, the therapist and bias the therapeutic process. Our
impression is that video recordings are well tolerated by patient and
therapist and are quickly assimilated into normality. However, video-
based observer ratings are very costly. For psychophysiological data
collection wearable devices were used. These were also well accepted.
It is important that a research collaborator and not the psychotherapist
is responsible for the mounting of these devices and the research pro-
cedures in general to maintain an as high as possible ecological validity.
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